Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus André J. Scheen Review Article 05 August 2014 Pages: 773 - 785
A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical Relevance Hanne HaahrTim Heise Review Article Open access 02 September 2014 Pages: 787 - 800
Impact of Cytochrome P450 2C19 Polymorphisms on Citalopram/Escitalopram Exposure: A Systematic Review and Meta-Analysis Ming ChangGunnel TybringJonatan D. Lindh Systematic Review 26 August 2014 Pages: 801 - 811
A Population Pharmacokinetic and Pharmacodynamic Modelling Approach to Support the Clinical Development of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Dependence Azmi F. NasserChristian HeidbrederMark K. Greenwald Original Research Article 12 July 2014 Pages: 813 - 824
Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition Zhe-Yi HuAndrea N. EdgintonRobert B. Parker Original Research Article 08 August 2014 Pages: 825 - 836
Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine Susanne JohanssonJessica ReadPaul Martin Original Research Article 13 August 2014 Pages: 837 - 847
Vancomycin Pharmacokinetic and Pharmacodynamic Models for Critically Ill Patients with Post-Sternotomy Mediastinitis Olivier ManginSaïk UrienChristophe Faisy Original Research Article 13 August 2014 Pages: 849 - 861